FDA Inspection 1230142 — Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (API Site)
The FDA completed an inspection of Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (API Site) on Jan 19, 2024 in Lianyungang. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 19, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lianyungang (China)